Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.055 USD | +2.86% | +1.84% | -27.67% |
02/05 | CUREVAC : A missed opportunity | |
26/04 | UBS Cuts CureVac Price Target to $14 From $18, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.67% | 67Cr | |
+27.40% | 4.82TCr | |
-0.94% | 4.17TCr | |
+43.45% | 4.1TCr | |
-5.26% | 2.88TCr | |
+10.22% | 2.56TCr | |
-22.89% | 1.9TCr | |
+8.07% | 1.29TCr | |
+29.29% | 1.2TCr | |
-2.07% | 1.18TCr |
- Stock Market
- Equities
- CVAC Stock
- News CureVac N.V.
- UBS Initiates Coverage on CureVac With Neutral Rating, $8 Price Target